Embolization using Imipenem(TIENAM) for refractory ulcer which cause is micro AVM

Embolization using Imipenem(TIENAM) for refractory ulcer which cause is micro AVM - Embolization using Imipenem for refractory ulcer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000022918

Enrollment

Registered

2016-07-01

Start date

2016-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

refractory ulcer

Interventions

0.5g Imipenem is dissolved with 10ml no-ionic iodine contract media. Inject the Imipenem solution until well-enhanced area of the ulcer disappear on DSA.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Refractory ulcer which cause is micro AVM. 2. It is difficult to embolize the vessel using an embolic material which is commercially available in Japan. 3. The patient has already given Informed consent.

Exclusion criteria

Exclusion criteria: 1. Refractory ulcer which cause is not micro AVM. 2. Hypersensitive patient with iodine contrast media or Carbapenem 3. Doctors judge a patient is inadequate for this study. 4. Patient under age.

Design outcomes

Primary

Measure	Time frame
1. Successful rate of embolization by Imipenem 2. Embolic effect of Imipenem for target vessels 3. Rate of adverse effect or complications	—

Countries

Japan

Contacts

Public ContactShinichi Ota

Shiga University of Medical Science Dept. of Radiology

junryuhei@belle.shiga-med.ac.jp077-548-2288

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026